CLINICAL TRIALS PROFILE FOR REMIMAZOLAM BESYLATE
✉ Email this page to a colleague
All Clinical Trials for REMIMAZOLAM BESYLATE
| Trial ID | Title | Status | Sponsor | Phase | Start Date | Summary |
|---|---|---|---|---|---|---|
| NCT04790734 ↗ | Remimazolam Besylate in Mechanically Ventilated ICU Patients | Not yet recruiting | Wuhan Union Hospital, China | Phase 3 | 2021-03-01 | The purpose of this study is to evaluate the efficacy and safety of remimazolam compared to propofol for sedation in mechanically ventilated ICU patients. |
| NCT04947345 ↗ | The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients | Not yet recruiting | Yichang Humanwell Pharmaceutical Co.,Ltd | Phase 3 | 2021-09-01 | This trial intends to evaluate Remimazolam Besylate's availability and safety compared with propofol. |
| NCT04947345 ↗ | The Availability and Safety Study of Remimazolam Besylate for Injection on Sedation of ERAS Patients | Not yet recruiting | Peking Union Medical College Hospital | Phase 3 | 2021-09-01 | This trial intends to evaluate Remimazolam Besylate's availability and safety compared with propofol. |
| NCT05103696 ↗ | A Comparative Study of Rimazolam and Propofol Combined With Etomidate in Gastroenteroscopy in Elderly Patients | Not yet recruiting | Peking University People's Hospital | N/A | 2021-11-01 | Studies have shown that etomidate combined with propofol in gastroscopy has high safety and lower incidence of hypoxia and hypotension, suggesting the advantages of etomidate combined with propofol in elderly patients. Remimazolam Besylate is a 1.1 class new drug that acts on GABA receptors and is metabolized by plasma esterase with fast metabolism time, only 1/7 of midazolam, which may be more suitable for elderly patients. Therefore, this study intends to explore the safety and effectiveness of two sedation schemes in gastroenteroscopy for elderly patients. |
| NCT05397886 ↗ | Comparison of Remimazolam With Flumazenil vs. Propofol During RFCA for Atrial Fibrillation | Not yet recruiting | Seoul National University Hospital | N/A | 2022-05-30 | This prospective randomized trial aims to compare recovery time from discontinuation of remimazolam followed by flumazenil administration vs. propofol total intravenous anesthesia as the main general anesthetics during radiofrequency catheter ablation treatment of atrial fibrillation. |
| NCT05423951 ↗ | Effect of Remimazolam and Propofol on Hemodynamic Stability During Anesthesia Induction in OPCAB Patients | Not yet recruiting | Seoul National University Hospital | N/A | 2022-06-30 | Remimazolam is a novel ultra-short-acting benzodiazepine. Several studies demonstrated that its efficacy as a sedative hypnotics for general anesthesia is non-inferior to propofol. However, evidence on the hemodynamic stability of remimazolam for the anesthesia induction in patients undergoing coronary artery bypass grafting is lacking. This prospective randomized trial aims to compare hemodynamic stability during anesthesia induction between remimazolam and propofol in patients undergoing coronary artery bypass grafting. |
| >Trial ID | >Title | >Status | >Sponsor | >Phase | >Start Date | >Summary |
Clinical Trial Conditions for REMIMAZOLAM BESYLATE
Condition Name
Clinical Trial Locations for REMIMAZOLAM BESYLATE
Clinical Trial Progress for REMIMAZOLAM BESYLATE
Clinical Trial Phase
Clinical Trial Sponsors for REMIMAZOLAM BESYLATE
Sponsor Name
